Alternate Doses and Dosing Schedules of Belantamab Mafodotin for Treatment of Triple-Class Refractory Multiple Myeloma
Clinical trial NCT05847569 · RECRUITING
Trial details
- NCT number
- NCT05847569
- Sponsor
- Mayo Clinic
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-04
- Primary completion
- 2029-06-29
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.